| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-09 |
详情>>
内部人交易：
Tammana Krishna等共交易11笔
|
| 2021-07-28 |
详情>>
股本变动：
变动后总股本3290.96万股
|
| 2021-07-28 |
详情>>
业绩披露：
2021年中报每股收益-1.4美元,归母净利润-4533.4万美元,同比去年增长-14.33%
|
| 2021-06-21 |
股东大会：
将于2021-07-26召开股东大会
会议内容 ▼▲
- 1.To approve appointment of Amy Coleman Redenbaugh as director subject to conditions precedent.
2.To approve appointment of Kenneth Virnig as director subject to conditions precedent.
3.To approve appointment of Mike Hoffmann as director subject to conditions precedent.
4.To approve appointment of Elizabeth Yates as director subject to conditions precedent.
5.To approve appointment of David Murphy as director subject to conditions precedent.
6.To approve appointment of Kristin Nimsger as director subject to conditions precedent.
7.To approve appointment of Jim Hagan as director subject to conditions precedent (proposals no. 1–7, the “Appointments,” and such proposals together, the “Governance Proposal”).
8.To review and approve a draft partial asset contribution agreement and approval of the contribution subject thereof, governed by the demerger legal regime (apport partiel d’actifs soumis au regime des scissions) by the Company to Talend SAS, a wholly-owned subsidiary of the Company, of all of its assets and liabilities, rights and obligations of any kind and other legal relationships in relation to its business in accordance with the terms of the Contribution Agreement (as this term is defined herein) (the “Demerger”) and delegation of powers to the board of directors (the “Board”) to implement such contribution (the “Demerger Proposal”).
9.To review and approve a draft cross-border merger plan by absorption of the Company by Tahoe AcquireCo B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) organized under the laws of the Netherlands, in accordance with the terms of the Merger Plan (as this term is defined herein) (the “Merger,” and such proposal, the “Merger Proposal” and the Governance Proposal, the Demerger Proposal, and the Merger Proposal together are referred to herein as the “Post-Offer Reorganization Proposals.” )
10.To give powers to carry out all filing and publication formalities required by law (the “Powers Proposal”).
|
| 2021-05-07 |
详情>>
业绩披露：
2021年一季报每股收益-0.72美元,归母净利润-2322.6万美元,同比去年增长-28.02%
|
| 2021-05-05 |
财报披露：
美东时间 2021-05-05 盘后发布财报
|
| 2021-04-29 |
股东大会：
将于2021-06-29召开股东大会
会议内容 ▼▲
- 1.To ratify the provisional appointment of Ms. Elissa Fink as Director;
2.To ratify the provisional appointment of Mr. Ryan Kearny as Director;
3.To renew the term of office of Mr. Ryan Kearny as Director;
4.To renew the term of office of Mr. Patrick Jones as Director;
5.To renew the term of office of Ms. Christal Bemont as Director;
6.To approve, on an advisory basis, the compensation of our named executive officers;
7.To approve the statutory financial statements for the year ended December 31, 2020;
8.To allocate earnings for the year ended December 31, 2020;
9.To approve the consolidated financial statements for the year ended December 31, 2020 prepared in accordance with IFRS;
10.To approve an indemnification agreement entered into with Ms. Elissa Fink (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code);
11.To approve an indemnification agreement entered into with Mr. Ryan Kearny (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code);
12.To approve a consulting agreement entered into with Mr. Michael Tuchen (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code);
13.To approve a separation agreement and release entered into with Mr. Laurent Bride (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code);
14.To ratify the selection of KPMG LLP as the independent registered public accountant for the Company for the fiscal year ending December 31, 2021 with respect to the Company’s financial statements prepared in accordance with generally accepted accounting principles in the United States for SEC reporting purposes;
15.To delegate authority to the board of directors to grant existing and/or newly issued free shares of the Company to all or certain employees and/or all or certain corporate officers of the Company or companies in the group, in accordance with the provisions of Articles L. 225-197-1 et seq. of the French Commercial Code;
16.To delegate authority to the board of directors to issue share warrants (bons de souscription d’actions), without shareholders’ preferential subscription right, for the benefit of a category of persons meeting certain characteristics;
17.To delegate authority to the board of directors to grant options to subscribe for new ordinary shares or options to purchase ordinary shares of the Company, pursuant to the provisions of Articles L. 225-177 et seq. of the French Commercial Code to all or certain employees and/or all or certain corporate officers of the Company or companies in the group, in accordance with the provisions of Articles L. 225-180 et seq. of the French Commercial Code;
18.To limit the amount of issues under Proposal Nos. 15, 16 and 17;
19.To delegate authority to the board of directors to increase the share capital by way of the issue of shares of the Company to participants in a company savings plan (plan d’épargne d’entreprise) established in accordance with Articles L. 3332-1 et seq. of the French Labor Code.
|
| 2021-03-10 |
复牌提示：
2021-03-10 08:25:02 停牌，复牌日期 2021-03-10 09:00:00
|
| 2021-03-01 |
详情>>
业绩披露：
2018年年报每股收益-1.31美元,归母净利润-3902.7万美元,同比去年增长-25.05%
|
| 2021-03-01 |
详情>>
业绩披露：
2020年年报每股收益-2.52美元,归母净利润-7958.2万美元,同比去年增长-29.47%
|
| 2020-11-09 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-1.91美元,归母净利润-5999.2万美元,同比去年增长-21.72%
|
| 2020-08-07 |
详情>>
业绩披露：
2020年中报每股收益-1.27美元,归母净利润-3965.1万美元,同比去年增长-10.36%
|
| 2020-06-12 |
股东大会：
将于2020-06-30召开股东大会
会议内容 ▼▲
- 1.To ratify the provisional appointment of Ms. Elizabeth Fetter as Director;
2.To ratify the provisional appointment of Ms. Christal Bemont as Director;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To approve the statutory financial statements for the year ended December 31, 2019;
5.To allocate earnings for the year ended December 31, 2019;
6.To approve the consolidated financial statements for the year ended December 31, 2019 prepared in accordance with IFRS;
7.To approve an indemnification agreement entered into with Ms. Elizabeth Fetter (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code);
8.To approve an indemnification agreement entered into with Ms. Christal Bemont (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code);
9.To approve a separation agreement and release entered into with Mr. Michael Tuchen (agreement referred to in Articles L. 225-38 et seq. of the French Commercial Code);
10.To set the amount of directors' compensation allocated to the board of directors;
11.To ratify the selection of KPMG LLP as the independent registered public accountant for the Company for the fiscal year ending December 31, 2020 with respect to the Company's financial statements prepared in accordance with generally accepted accounting principles in the United States for SEC reporting purposes;
12.To ratify the transfer of the headquarters of the Company pursuant to Article L. 225-36 of the French Commercial Code;
13.To delegate authority to the board of directors to increase the share capital by issuing ordinary shares, or any securities giving access to the Company's share capital, with shareholders' preferential subscription right;
14.To delegate authority to the board of directors to increase the share capital by issuing ordinary shares, or any securities giving access to the Company's share capital, without shareholders' preferential subscription right, by way of a public offering excluding offerings referred to in Article L. 411-2 1° of the French Monetary and Financial Code;
15.To delegate authority to the board of directors to increase the share capital by issuing ordinary shares, or any securities giving access to the Company's share capital, without shareholders' preferential subscription right, by way of an offering referred to in Article L. 411-2 1° of the French Monetary and Financial Code;
16.To delegate authority to the board of directors to increase the share capital by issuing ordinary shares of the Company, without shareholders' preferential subscription right, for the benefit of a first category of persons meeting certain characteristics;
17.To delegate authority to the board of directors to increase the share capital by issuing ordinary shares of the Company, without shareholders' preferential subscription right, for the benefit of a second category of persons meeting certain characteristics;
18.To delegate authority to the board of directors to increase the number of securities to be issued as a result of a share capital increase pursuant to the delegations in Proposal Nos. 13 to 15 above, with or without shareholders' preferential subscription right;
19.To approve the overall limits on the amount of ordinary shares to be issued pursuant to the delegations in Proposal Nos. 13 to 18 above;
20.To delegate authority to the board of directors to increase the share capital by capitalization of premiums, reserves, profits or other sums allowed to be capitalized;
21.To delegate authority to the board of directors to grant existing and/or newly issued free shares of the Company to all or certain employees and/or all or certain corporate officers of the Company or companies in the group, in accordance with the provisions of Articles L. 225-197-1 et seq. of the French Commercial Code;
22.To delegate authority to the board of directors to issue share warrants (bons de souscription d'actions), without shareholders' preferential subscription right, for the benefit of a category of persons meeting certain characteristics;
23.To delegate authority to the board of directors to grant options to subscribe for new ordinary shares or options to purchase ordinary shares of the Company, pursuant to the provisions of Articles L. 225-177 et seq. of the French Commercial Code to all or certain employees and/or all or certain corporate officers of the Company or companies in the group, in accordance with the provisions of Articles L. 225-180 et seq. of the French Commercial Code;
24.To limit the amount of issues under Proposal Nos. 21, 22 and 23;
25.To delegate authority to the board of directors to increase the share capital by way of the issue of shares of the Company to participants in a company savings plan (plan d'épargne d'entreprise) established in accordance with Articles L. 3332-1 et seq. of the French Labor Code;
26.To amend the Bylaws in accordance with certain provisions of law n°2019-744 of 19 July 2019 and law n°2019-486 of 22 May 2019.
|
| 2020-05-08 |
详情>>
业绩披露：
2019年一季报每股收益-0.59美元,归母净利润-1774.5万美元,同比去年增长-75.43%
|
| 2020-05-08 |
详情>>
业绩披露：
2020年一季报每股收益-0.58美元,归母净利润-1814.2万美元,同比去年增长-2.24%
|
| 2020-03-17 |
详情>>
业绩披露：
2019年年报每股收益-2.01美元,归母净利润-6146.9万美元,同比去年增长-57.5%
|
| 2019-11-08 |
详情>>
业绩披露：
2019年三季报(累计)每股收益-1.62美元,归母净利润-4928.7万美元,同比去年增长-75.38%
|
| 2019-08-09 |
详情>>
业绩披露：
2019年中报每股收益-1.18美元,归母净利润-3592.8万美元,同比去年增长-90.56%
|
| 2019-04-30 |
股东大会：
将于2019-06-25召开股东大会
会议内容 ▼▲
- 1.To renew the term of office of Mr. Michael Tuchen;
2.To renew the term of office of Mr. John Brennan;
3.To renew the term of office of Mr. Thierry Sommelet;
4.To renew the term of office of Mr. Steve Singh;
5.To renew the term of office of Ms. Nora Denzel;
6.To approve, on an advisory basis, the compensation of our named executive officers;
7.To recommend, on an advisory basis, to hold an advisory vote to approve the compensation for the named executive officers of the Company every year;
8.To recommend, on an advisory basis, to hold an advisory vote to approve the compensation for the named executive officers of the Company every two years;
9.To recommend, on an advisory basis, to hold an advisory vote to approve the compensation for the named executive officers of the Company every three years;
10.To approve the statutory financial statements for the year ended December 31, 2018; discharge of directors and statutory auditors;
11.To allocate earnings for the year ended December 31, 2018;
12.To approve the consolidated financial statements for the year ended December 31, 2018;
13.To review the agreements described under articles L. 225-38 et seq. of the French Commercial Code;
14.To amend the quorum requirements for meetings of the shareholders—corresponding amendment to article 20 of the By-laws;
15.To delegate authority to the Board of Directors to increase the Company's share capital by issuing ordinary shares, or any securities granting access to the Company's share capital, while preserving shareholders' preferential subscription rights;
16.To delegate authority to the Board of Directors to increase the Company's share capital by issuing ordinary shares, or any securities granting access to the Company's share capital, through a public offering, with waiver of shareholders' preferential subscription rights;
17.To delegate authority to the Board of Directors to increase the Company's share capital by issuing ordinary shares, or any securities granting access to the Company's share capital, in the context of a private placement, with waiver of shareholders' preferential subscription rights;
18.To delegate authority to the Board of Directors to increase the number of securities to be issued as a result of a share capital increase pursuant to the delegations in Proposal Nos. 15 to 17 above, with or without shareholders' preferential subscription rights;
19.To approve the overall limits on the amount of ordinary shares to be issued pursuant to the delegations in Proposal Nos. 15 to 18 above;
20.To delegate authority to the board of directors to carry out the free allocation of existing shares or newly issued shares to employees of the Company or companies in the group and / or to certain corporate officers of the Company, in accordance with the provisions of articles L. 225-197-1 et seq. of the French commercial code;
21.To delegate authority to the board of directors to issue ordinary share purchase warrants with waiver of shareholders' preferential subscription rights in favor of a category of persons meeting certain determined criteria;
22.To limit the amount of issues under Proposal Nos. 20 and 21;
23.To delegate authority to the board of directors to increase the share capital for the issuance of shares of the Company to participants in a company savings plan established in accordance with article L. 3332-1 et seq. of the French Labor Code;
24.To delegate authority to the board of directors to increase the share capital for the issuance of Company shares with waiver of shareholders' preferential subscription rights in favor of a first category of persons meeting certain determined criteria;
25.To delegate authority to the board of directors to increase the share capital for the issuance of Company shares with waiver of shareholders' preferential subscription right in favor of a second category of persons meeting certain determined criteria;
26.To limit the amount of the issuances implemented under Proposal Nos. 23, 24 and 25.
|
| 2018-05-24 |
股东大会：
将于2018-06-26召开股东大会
会议内容 ▼▲
- Within the authority of the Ordinary Shareholders’ Meeting:
1.Approval of the financial statements for the year ended December 31, 2017 - Discharge of the directors and statutory auditors.
2.Allocation of the results for the year ended December 31, 2017.
3.Approval of the consolidated financial statements for the year ended December 31, 2017.
4.Examination of the agreements referred to in Articles L. 225-38 et seq. of the French Commercial Code.
5.Renewal of the statutory auditors’ term of office.
6.Ratification of the provisional appointment of Ms. Nora Denzel as Director.
7.Ratification of the provisional appointment of Mr. Brian Lillie as Director.
8.Renewal of the term of office of Ms. Nanci Caldwell as Director.
9.Renewal of the term of office of Mr. Patrick Jones as Director.
10.Renewal of the term of office of Mr. Brian Lillie as Director.
11.Appointment of Mr. Mark Nelson as Director.
Within the authority of the Extraordinary Shareholders’ Meeting:
12.Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares and / or other securities, with preservation of preferential subscription rights of the shareholders.
13.Delegation of authority to be granted to the Board of Directors to increase the share capital by issuing ordinary shares and / or other securities, with cancellation of the preferential subscription right of the shareholders and offer to the public.
14.Delegation of authority to be granted to the Board of Directors to increase the capital by issuing ordinary shares and / or other securities, with cancellation of the preferential subscription right of the shareholders, to be issued in connection with an offer to qualified investors or a limited group of investors as contemplated by Article L. 411-2 II of the French Monetary and Financial Code.
15.Delegation to the Board of Directors to increase the number of securities to be issued in the event of a capital increase with or without preferential subscription rights pursuant to the above delegations.
16.Determination of overall limitations on the amount of issuances made pursuant to the above delegations.
17.Delegation of authority granted to the Board of Directors to increase the share capital by capitalization of premiums, reserves, profits or other amounts which may be capitalized.
18.Authorization to be given to the Board of Directors to offer existing or newly issued free shares in accordance with the provisions of Articles L. 225-197-1 et seq. of the French Commercial Code.
19.Delegation of authority to be granted to the Board of Directors for the purpose of issuing and allocating warrants, with cancellation of the preferential subscription right of the shareholders in favor of a category of persons meeting certain criteria.
20.Setting of overall limitations on the amount of issuances made pursuant to the Eighteenth Resolution and Nineteenth Resolution above.
21.Delegation to be granted to the Board of Directors to increase the share capital by issuing shares of the Company for the benefit of employees adhering to the Company savings plan established pursuant to Articles L. 3332-1 et seq. of the French Labor Code.
22.Delegation to be granted to the Board of Directors to increase the share capital through the issuance of shares, with cancellation of the preferential subscription right of the shareholders in favor of a first category of persons meeting specific criteria.
23.Delegation to be granted to the Board of Directors to increase the share capital through the issuance of shares, with cancellation of the preferential subscription right of the shareholders in favor of a second category of persons meeting specific criteria.
24.Setting of overall limitations on the amount of issuances made pursuant to the Twenty-First through Twenty-Third Resolutions above.
|
| 2017-05-03 |
股东大会：
将于2017-06-06召开股东大会
会议内容 ▼▲
- 1.Board of Directors’ management report and presentation by the Board of Directors of the annual financial statements for the year ended December 31, 2016.
2.Statutory Auditors’ reports on the financial statements for the year ended December 31, 2016 and on the agreements described under articles L. 225-38 et seq. of the French Commercial Code.
3.Approval of the annual financial statements for the year ended December 31, 2016 — Full discharge to the Directors and Statutory Auditors.
4.Allocation of earnings for the year ended December 31, 2016, reconstitution of the Company’s net equity.
5.Allocation of the amount recorded in the “unavailable reserve” account to “retained earnings”.
6.Group Management report and presentation by the Board of the consolidated financial statements for the year ended December 31, 2016.
7.Statutory Auditors’ report on the consolidated financial statements for the year ended December 31, 2016.
8.Approval of the consolidated financial statements for the year ended December 31, 2016.
9.Examination of the agreements described under articles L. 225-38 et seq. of the French Commercial Code.
10.Ratification of the provisional appointment of Mr. Steven Singh as a Director.
11.Ratification of the provisional appointment of Ms. Nanci Caldwell as a Director.
12.Approval of the 2017 stock option plan adopted by the Board of Directors at its meeting on April 20, 2017.
13.Setting of the amount of Directors’ fees allocated to the Board of Directors.
14.Amendment to article 4 “registered office” of the Bylaws to comply with applicable legal provisions.
15.Authorization to be given to the Board of Directors to grant Company share subscription or purchase options, in accordance with the provisions of articles L. 225-177 et seq. of the French Commercial Code.
16.Delegation to be granted to the Board of Directors to issue and allocate free employee warrants, with waiver of shareholders’ preferential subscription rights, for the benefit of Company employees and managers, or of a company in which the Company holds at least 75% of capital or voting rights.
17.Authorization to be given to the Board of Directors to carry out the free allocation of existing or newly issued shares, in accordance with the provisions of articles L. 225-197-1 et seq. of the French Commercial Code.
18.Delegation to be granted to the Board of Directors to issue and allocate warrants, with the waiver of shareholders’ preferential subscription rights, in favor of a category of persons who meet specified characteristics.
19.Setting of an overall ceiling on the amount of issuances that can be carried out by virtue of the authorizations to grant the above-mentioned options, free shares, employee warrants and warrants.
20.Delegation to be granted to the Board of Directors for the purpose of increasing the share capital by issuing Company shares for the benefit of employees who are members of a Company savings plan, established in accordance with articles L. 3332-1 et. seq. of the French Commercial Code.
21.Delegation to be granted to the Board of Directors to increase the share capital through the issuance of shares, with the waiver of shareholders’ preferential subscription rights, in favor of a first category of persons who meet specified characteristics.
22.Delegation to be granted to the Board of Directors to increase the share capital through the issuance of shares, with the waiver of shareholders’ preferential subscription rights, in favor of a second category of persons who meet specified characteristics.
23.Setting of an overall ceiling on the amount of issuances that can be carried out by virtue of the delegations set forth in points 20-22 above.
|